Abstract
In this chapter, we review selected literature reflecting on biomedical interventions that prevent HIV infection, and regarding treatment as prevention (TasP), also assist those living with HIV given its goal to effectively reduce infectivity by reducing people living with HIV’s viral load to an undetectable level. Unfortunately, in context to rural health care, little empirical data exists on these interventions, as standalone or combined approaches. What we know about TasP, occupational postexposure prophylaxis (oPEP), nonoccupational postexposure prophylaxis (nPEP), and pre-exposure prophylaxis (PrEP) is that they work, at least in clinical trials they worked. Theoretically, each poses significant potential to reduce HIV transmissions in all geographical settings. Realizing their potential in real-world settings, including rural areas, will require more resources that have yet to be allocated for large-scale implementation, especially concerning nPEP and PrEP. Ideally, our response system should consider developing integrated approaches that include all these interventions, in all jurisdictions. All the more critical, it will be essential to mobilize biomedical (e.g. medications and condoms), behavioral (e.g. cleaning needles prior to use or not sharing needles), and structural (e.g. eliminating stigma attached to HIV infection) interventions to achieve large-scale HIV prevention. In sum, since the discovery of HIV over three and a half decades ago, we have gained considerable knowledge that can and has improved our efforts to prevent (and treat) HIV. Now is the time to make this knowledge work to our advantage with a vision to end HIV transmissions.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Notes
- 1.
The 2015 HIV outbreak in Austin, Indiana (a town of ~4000) and pervasively high rates of prescription drug abuse suggests this trend may not hold (O’Malley, 2015).
- 2.
Even with the decline in their rate over the prior decade, African American women remain disproportionately impacted compared to women of other racial backgrounds (60% of women’s HIV cases are African-American) (CDC, 2016a).
- 3.
Texas, Oklahoma, Missouri, Louisiana, Mississippi, Alabama, Tennessee, Kentucky, Georgia, Florida, North and South Carolina, Virginia, Maryland, West Virginia and Delaware.
References
Adimora, A. A., Ramirez, C., Schoenbach, V. J., & Cohen, M. (2014). Policies and politics that promote HIV infection in the southern United States. AIDS, 28, 1393–1397.
American Federation for AIDS Research [amfAR]. (2016). Statistics—United States. Retrieved from http://www.amfar.org/about-hiv-and-aids/facts-and-stats/statistics–united-states/
Annan, S. L. (2006). Sexual violence in rural areas: A review of the literature. Family & Community Health, 29(3), 164–168.
AVERT. (2016). Treatment as prevention. Retrieved from https://www.avert.org/professionals/hiv-programming/prevention/treatment-as-prevention
Baeten, J., & Celum, C. (2011, July). Antiretroviral pre-exposure prophylaxis for HIV-1 prevention among heterosexual African men and women: The partners PrEP study. In 6th IAS conference on HIV pathogenesis, treatment and prevention (pp. 17–20). Rome: IAS.
Buchbinder, S. P., Glidden, D. V., Liu, A. Y., McMahan, V., Guanira, J. V., Mayer, K. H., … & Grant, R. M. (2014). HIV pre-exposure prophylaxis in men who have sex with men and transgender women: A secondary analysis of a phase 3 randomised controlled efficacy trial. The Lancet Infectious Diseases, 14(6), 468–475.
Carrieri, M. P., Bendiane, M. K., Moatti, J. P., & Rey, D. (2006). Access to HIV prophylaxis for survivors of sexual assault: The tip of the iceberg (vol. 11, pp. 391, 2006). Antiviral Therapy, 11(7), 953–953.
CDC. (1990). Public Health Service statement on management of occupational exposure to human immunodeficiency virus, including considerations regarding zidovudine postexposure use. MMWR Morbidity and Mortality Weekly Report, 39(RR01), 1–14.
CDC. (2011). Surveillance of occupationally acquired HIV/AIDS in healthcare personnel, as of December 2010. Retrieved from http://www.cdc.gov/HAI/organisms/hiv/Surveillance-Occupationally-Acquired-HIV-AIDS.html
CDC. (2015a). HIV in the Southern United States. Retrieved from http://www.cdc.gov/hiv/pdf/policies/cdc-hiv-in-the-south-issue-brief.pdf
CDC. (2015b). HIV cost effectiveness. Retrieved from http://www.cdc.gov/hiv/programresources/guidance/costeffectiveness/index.html
CDC. (2016a). Trends in U.S. HIV diagnoses, 2005–2014. Retrieved from http://www.cdc.gov/nchhstp/newsroom/docs/factsheets/hiv-data-trends-fact-sheet-508.pdf
CDC. (2016b). Lifetime risk of HIV diagnosis. Retrieved from http://www.cdc.gov/nchhstp/newsroom/2016/croi-press-release-risk.html
CDC. (2016c). PrEP. Retrieved from http://www.cdc.gov/hiv/basics/prep.html
CDC. (2016d). Updated guidelines for antiretroviral postexposure prophylaxis after sexual, injection drug use, or other nonoccupational exposure to HIV—United States, 2016. Retrieved from http://www.cdc.gov/hiv/pdf/programresources/cdc-hiv-npep-guidelines.pdf
CDC. (n.d.). HIV surveillance in urban and nonurban areas through 2013. Retrieved from www.cdc.gov/hiv/ppt/2013-Urban-Nonurban-slides_508-REV-5.pptx
Centers for Disease Control [CDC]. (1981). Pneumocystis pneumonia — Los Angeles. Morbidity and Mortality Weekly Report, 30(21), 1–3. Retrieved from http://www.cdc.gov/mmwr/preview/mmwrhtml/june_5.htm
Chan, P. A., Mena, L., Patel, R., Oldenburg, C. E., Beauchamps, L., Perez-Brumer, A. G., … & Nunn, A. (2016). Retention in care outcomes for HIV pre-exposure prophylaxis implementation programmes among men who have sex with men in three US cities. Journal of the International AIDS Society, 19(1).
Choopanya, K., Martin, M., Suntharasamai, P., Sangkum, U., Mock, P. A., Leethochawalit, M., … & Chuachoowong, R. (2013). Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): A randomised, double-blind, placebo-controlled phase 3 trial. The Lancet, 381(9883), 2083–2090.
Cohen, M. S., Chen, Y. Q., McCauley, M., Gamble, T., Hosseinipour, M. C., Kumarasamy, N., … & Godbole, S. V. (2011). Prevention of HIV-1 infection with early antiretroviral therapy. New England Journal of Medicine, 365(6), 493–505.
Cohen, M. S., McCauley, M., & Gamble, T. R. (2012). HIV treatment as prevention and HPTN 052. Current Opinion in HIV and AIDS, 7(2), 99.
Connor, E. M., Sperling, R. S., Gelber, R., Kiselev, P., Scott, G., O’Sullivan, M. J., … & Jimenez, E. (1994). Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. New England Journal of Medicine, 331(18), 1173–1180.
Denning, P., & DiNenno, E. (2015). Communities in crisis: Is there a generalized HIV epidemic in impoverished urban areas of the United States? Retrieved from http://www.cdc.gov/hiv/group/poverty.html
Fulton County Task Force on HIV/AIDS. (2015). Phase I progress report: Building the strategy to end AIDS in Fulton County. Retrieved from http://www.sisterlove.org/wp-content/uploads/2014/10/2015-1201-Strategy-to-End-AIDS-in-Fulton-County-Phase-I.pdf
Georgia Department of Public Health. (n.d. a). HIV surveillance fact sheet, 2013. Retrieved from http://dph.georgia.gov/sites/dph.georgia.gov/files/HIV_EPI_Fact_Sheet_Surveillance_2013.pdf
Georgia Department of Public Health. (n.d. b). HIV surveillance summary, Georgia 2013. Retrieved from http://dph.georgia.gov/sites/dph.georgia.gov/files/HIV_EPI_2013_Surveillance_Summary.pdf
Gilliam, B. L., Dyer, J. R., Fiscus, S. A., Marcus, C., Zhou, S., Wathen, L., … & Eron Jr, J. J. (1997). Effects of reverse transcriptase inhibitor therapy on the HIV-1 viral burden in semen. JAIDS Journal of Acquired Immune Deficiency Syndromes, 15(1), 54–60.
Grant, R. M., Lama, J. R., Anderson, P. L., McMahan, V., Liu, A. Y., Vargas, L., … & Montoya-Herrera, O. (2010). Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. New England Journal of Medicine, 363(27), 2587–2599.
Grant, R. M., Anderson, P. L., McMahan, V., Liu, A., Amico, K. R., Mehrotra, M., … & Buchbinder, S. (2014). Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: A cohort study. The Lancet infectious diseases, 14(9), 820–829.
Hall, H. I., Li, J., & McKenna, M. T. (2005). HIV in predominantly rural areas of the United States. The Journal of Rural Health, 21(3), 245–253.
Heckman, T. G., Somlai, A. M., Peters, J., Walker, J., Otto-Salaj, L., Galdabini, C. A., et al. (1998). Barriers to care among persons living with HIV/AIDS in urban and rural areas. AIDS Care, 10(3), 365–375.
Kaplan, J. E., Dominguez, K., Jobarteh, K., & Spira, T. J. (2015). Postexposure prophylaxis against human immunodeficiency virus (HIV): New guidelines from the WHO: A perspective. Clinical Infectious Diseases, 60(suppl 3), S196–S199.
Kempf, M. C., McLeod, J., Boehme, A. K., Walcott, M. W., Wright, L., Seal, P., … & Moneyham, L. (2010). A qualitative study of the barriers and facilitators to retention-in-care among HIV-positive women in the rural southeastern United States: Implications for targeted interventions. AIDS Patient Care and STDs, 24(8), 515–520.
Kumar, R. S. (2008). Post exposure prophylaxis in HIV. Oral Hypoglycemic Agents: Where Do We Stand Today? 18, 752.
Lieb, S., Thompson, D. R., Misra, S., Gates, G. J., Duffus, W. A., Fallon, S. J., … & Southern AIDS Coalition MSM Project Team. (2009). Estimating populations of men who have sex with men in the southern United States. Journal of Urban Health, 86(6), 887–901.
McCausland, J. B., Linden, J. A., Degutis, L. C., Ramanujam, P., Sullivan, L. M., & D’Onofrio, G. (2003). Nonoccupational postexposure HIV prevention: Emergency physicians’ current practices, attitudes, and beliefs. Annals of Emergency Eedicine, 42(5), 651–656.
Molina, J. M., Capitant, C., Spire, B., Pialoux, G., Cotte, L., Charreau, I., … & Raffi, F. (2015). On-demand preexposure prophylaxis in men at high risk for HIV-1 infection. New England Journal of Medicine, 373(23), 2237–2246.
Montaner, J. S., Hogg, R., Wood, E., Kerr, T., Tyndall, M., Levy, A. R., et al. (2006). The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic. The Lancet, 368(9534), 531–536.
National Rural Health Association. (n.d.). HIV/AIDS in rural America: Disproportionate impact on minority and multicultural populations. Retrieved fromfile:///C:/Users/necarnes/Downloads/HIVAIDSRuralAmericapolicybriefApril2014%20(2).pdf
O’Malley, J. (2015, April 24). Indiana HIV outbreak, hepatitis C epidemic sparks CDC alert. The Indianapolis Star. Retrieved from http://www.indystar.com/story/news/2015/04/24/indiana-hiv-outbreak-hepatitis-epidemic-sparks-cdc-alert/26310539/
Ohl, M. E., & Perencevich, E. (2011). Frequency of human immunodeficiency virus (HIV) testing in urban versus rural areas of the United States: Results from a nationally-representative sample. BMC Public Health, 11(1), 1.
Palella, F. J., Delaney, K. M., Moorman, A. C., Loveless, M. O., Fuhrer, J., Satten, G. A., … & Holmberg, S. D. (1998). HIV Outpatient Study Investigators Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. New England Journal of Medicine, 338(13), 853–860.
Pinkerton, S. D., Holtgrave, D. R., & Bloom, F. R. (1998). Cost-effectiveness of post-exposure prophylaxis following sexual exposure to HIV. AIDS, 12, 1067–1078.
Pinkerton, S. D., Martin, J. N., Roland, M. E., Katz, M. H., Coates, T. J., & Kahn, J. O. (2004). Cost-effectiveness of postexposure prophylaxis after sexual or injection-drug exposure to human immunodeficiency virus. Archives of Internal Medicine, 164(1), 46–54.
Preston, D. B., D’Augelli, A. R., Kassab, C. D., & Cain, R. E. (2004). The influence of stigma on the sexual risk behavior of rural men who have sex with men. AIDS Education and Prevention, 16(4), 291.
Quinn, T. C., Wawer, M. J., Sewankambo, N., Serwadda, D., Li, C., Wabwire-Mangen, F., … & Gray, R. H. (2000). Viral load and heterosexual transmission of human immunodeficiency virus type 1. New England Journal of Medicine, 342(13), 921–929.
Reif, S., Golin, C. E., & Smith, S. R. (2005). Barriers to accessing HIV/AIDS care in North Carolina: Rural and urban differences. AIDS Care, 17(5), 558–565.
Reif, S. S., Whetten, K., Wilson, E. R., McAllaster, C., Pence, B. W., Legrand, S., et al. (2014). HIV/AIDS in the Southern USA: A disproportionate epidemic. AIDS Care, 26(3), 351–359.
Rodriguez, A., Castel, A. D., Parish, C. L., Willis, S., Feaster, D. J., Kharfen, M., … & Metsch, L. R. (2013). HIV medical providers’ perceptions of the use of antiretroviral therapy as non-occupational post-exposure prophylaxis (nPEP) in two major metropolitan areas. Journal of Acquired Immune Deficiency Syndromes (1999), 64(0 1).
Rural Center for AIDS/STD Prevention. (2009). HIV/AIDS in rural America: Challenges and promising strategies. Retrieved from http://www.indiana.edu/~aids/factsheets/factsheet23.pdf
Schreiner, M. C., Stingl, G., Rieger, A., & Jalili, A. (2013). P4. 049 lopinavir/ritonavir in combination with tenofovir/emtricitabine as post exposure prophylaxis (PEP) to HIV-an effective and well tolerated regimen. Sexually Transmitted Infections, 89(Suppl 1), A303–A304.
Sowell, R. L., Lowenstein, A., Moneyham, L., Demi, A., Mizuno, Y., & Seals, B. F. (1997). Resources, stigma, and patterns of disclosure in rural women with HIV infection. Public Health Nursing, 14(5), 302–312.
Sutton, M., Anthony, M. N., Vila, C., McLellan-Lemal, E., & Weidle, P. J. (2010). HIV testing and HIV/AIDS treatment services in rural counties in 10 southern states: Service provider perspectives. The Journal of Rural Health, 26(3), 240–247.
Thigpen, M. C., Kebaabetswe, P. M., Paxton, L. A., Smith, D. K., Rose, C. E., Segolodi, T. M., … & Mutanhaurwa, R. (2012). Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. New England Journal of Medicine, 367(5), 423–434.
U.S. Department of Agriculture. (2015). Rural poverty and well-being. Retrieved from http://www.ers.usda.gov/topics/rural-economy-population/rural-poverty-well-being/geography-of-poverty.aspx
U.S. Public Health Service. (2014). Preexposure Prophylaxis for the prevention of HIV infection in the United States—2014 clinical practice guideline. Retrieved from http://www.cdc.gov/hiv/pdf/prepguidelines2014.pdf
Van Damme, L., Corneli, A., Ahmed, K., Agot, K., Lombaard, J., Kapiga, S., … & Temu, L. (2012). Preexposure prophylaxis for HIV infection among African women. New England Journal of Medicine, 367(5), 411–422.
Vyavaharkar, M., Glover, S., Leonhirth, D., & Probst, J. (2013). HIV/AIDS in rural America: Prevalence and service availability. Retrieved from http://rhr.sph.sc.edu/report/%2811-1%29HIV%20AIDS%20in%20Rural%20America.pdf
World Health Organization [WHO]. (n.d.). Global health observatory (GHO) data—HIV/AIDS. Retrieved from http://www.who.int/gho/hiv/en/
Yannessa, J. F., Reece, M., & Basta, T. B. (2008). HIV provider perspectives: The impact of stigma on substance abusers living with HIV in a rural area of the United States. AIDS Patient Care and STDs, 22(8), 669–675.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Carnes, N.A., Malone, J., Helms, J. (2017). HIV Prevention: Treatment as Prevention (TasP), Occupational Postexposure Prophylaxis (oPEP), Nonoccupational Postexposure Prophylaxis (nPEP), and Pre-exposure Prophylaxis (PrEP). In: Parks, F., Felzien, G., Jue, S. (eds) HIV/AIDS in Rural Communities. Springer, Cham. https://doi.org/10.1007/978-3-319-56239-1_5
Download citation
DOI: https://doi.org/10.1007/978-3-319-56239-1_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-56238-4
Online ISBN: 978-3-319-56239-1
eBook Packages: MedicineMedicine (R0)